Systematic Review: Adverse Events of Fecal Microbiota Transplantation
- PMID: 27529553
- PMCID: PMC4986962
- DOI: 10.1371/journal.pone.0161174
Systematic Review: Adverse Events of Fecal Microbiota Transplantation
Abstract
Background: Fecal microbiota transplantation (FMT) is a microbiota-based therapy that shows therapeutic potential in recurrent or refractory Clostridium difficile infections and other intestinal or extra-intestinal disorders. Nonetheless, adverse events (AEs) remain a major challenge in the application of FMT.
Aim: To review the AEs of FMT and to address the concerns of safety during the procedure.
Methods: Publications were retrieved in the databases of Medline, Embase and Cochrane Library. AEs were classified according to their causality with FMT or their severity.
Results: A total of 7562 original articles about FMT were identified in this study, 50 of them fulfilled the inclusion criteria. Totally 78 kinds of AEs were revealed enrolled in these 50 selected publications. The total incidence rate of AEs was 28.5%. Among the 42 publications, 5 kinds were definitely and 38 kinds were probably related to FMT. The commonest FMT-attributable AE was abdominal discomfort, which was reported in 19 publications. For upper gastrointestinal routes of FMT, 43.6% (89/204) patients were compromised by FMT-attributable AE, while the incidence dropped to 17.7% (76/430) for lower gastrointestinal routes. In contrast, the incidences of serious adverse events (SAEs) were 2.0% (4/196) and 6.1% (40/659) for upper and lower gastrointestinal routes, respectively. A total of 44 kinds of SAEs occurred in 9.2% patients, including death (3.5%, 38/1089), infection (2.5%, 27/1089), relapse of inflammatory bowel diseases (0.6%, 7/1089) and Clostridium difficile infection (0.9%, 10/1089).
Conclusion: Consequently, both AEs and SAEs are not rare and should be carefully monitored throughout FMT. However, high quality randomized controlled trials are still needed for the more definite incidence of AEs of FMT.
Conflict of interest statement
Figures
Similar articles
-
Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020.Aliment Pharmacol Ther. 2021 Jan;53(1):33-42. doi: 10.1111/apt.16148. Epub 2020 Nov 7. Aliment Pharmacol Ther. 2021. PMID: 33159374 Review.
-
Fecal transplantation for treatment of inflammatory bowel disease.Cochrane Database Syst Rev. 2018 Nov 13;11(11):CD012774. doi: 10.1002/14651858.CD012774.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2023 Apr 25;4:CD012774. doi: 10.1002/14651858.CD012774.pub3 PMID: 30480772 Free PMC article. Updated.
-
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2. Cochrane Database Syst Rev. 2023. PMID: 37096495 Free PMC article. Review.
-
Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.Ann Intern Med. 2016 Nov 1;165(9):609-616. doi: 10.7326/M16-0271. Epub 2016 Aug 23. Ann Intern Med. 2016. PMID: 27547925 Free PMC article. Clinical Trial.
-
The global incidence of adverse events associated with fecal microbiota transplantation in children over the past 20 years: A systematic review and meta-analysis.J Gastroenterol Hepatol. 2022 Nov;37(11):2031-2038. doi: 10.1111/jgh.15996. Epub 2022 Sep 23. J Gastroenterol Hepatol. 2022. PMID: 36066910
Cited by
-
Acute Radiation Syndrome and the Microbiome: Impact and Review.Front Pharmacol. 2021 May 18;12:643283. doi: 10.3389/fphar.2021.643283. eCollection 2021. Front Pharmacol. 2021. PMID: 34084131 Free PMC article. Review.
-
Controlling skin microbiome as a new bacteriotherapy for inflammatory skin diseases.Inflamm Regen. 2022 Sep 1;42(1):26. doi: 10.1186/s41232-022-00212-y. Inflamm Regen. 2022. PMID: 36045395 Free PMC article. Review.
-
Precision Medicine and Public Health: New Challenges for Effective and Sustainable Health.J Pers Med. 2021 Feb 16;11(2):135. doi: 10.3390/jpm11020135. J Pers Med. 2021. PMID: 33669364 Free PMC article. Review.
-
Efficacy and Safety of Fecal Microbiota Transplantation for Clearance of Multidrug-Resistant Organisms under Multiple Comorbidities: A Prospective Comparative Trial.Biomedicines. 2022 Sep 26;10(10):2404. doi: 10.3390/biomedicines10102404. Biomedicines. 2022. PMID: 36289668 Free PMC article.
-
Long-term safety and efficacy of fecal microbiota transplantation in 74 children: A single-center retrospective study.Front Pediatr. 2022 Oct 11;10:964154. doi: 10.3389/fped.2022.964154. eCollection 2022. Front Pediatr. 2022. PMID: 36304525 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
